Polifarma Strengthens European Foothold with Hennig Acquisition
Deal News | Feb 17, 2025 | Finance Community IT - 1 Corporate M&A
Polifarma, an Italian pharmaceutical company based in Rome, has finalized the acquisition of Hennig Arzneimittel GmbH & Co. KG, a German pharmaceutical company with a 120-year history. The acquisition, assisted by Deloitte Financial Advisory, aims to strengthen Polifarma's position in major European markets. Deloitte provided comprehensive advisory and due diligence services, covering business, financial, legal, and tax aspects. EY Legal Transaction also supported Polifarma as a legal advisor. The acquisition will create a group with over €181 million in projected revenues by 2025, leveraging production synergies to enhance profitability and accelerate international expansion. Hennig, renowned for its innovative drugs in various domains and contract manufacturing services, was advised by RSM Ebner Stolz.
Sectors
- Pharmaceutical
- Financial Advisory
- Legal Services
Geography
- Italy – Polifarma, the acquiring company, is based in Rome, Italy.
- Germany – Hennig Arzneimittel, the acquired company, operates out of Germany, marking a strategic international acquisition for Polifarma.
Industry
- Pharmaceutical – The acquisition involves Polifarma, an Italian pharmaceutical company, acquiring Hennig Arzneimittel, a German pharmaceutical firm with expertise in drug development and CDMO services.
- Financial Advisory – Deloitte provided financial advisory services, offering strategic insights and due diligence, vital in ensuring the successful acquisition of Hennig by Polifarma.
- Legal Services – EY and RSM Ebner Stolz were actively involved in providing legal services, ensuring compliance and negotiation of agreements during the acquisition process.
Financials
- €181 million – Projected revenue for 2025 due to the acquisition and the resultant synergies.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Polifarma | Acquirer | Company | An Italian pharmaceutical company focused on the commercialization and distribution of medicines and medical devices. |
| Hennig Arzneimittel GmbH & Co. KG | Target | Company | A German pharmaceutical firm with extensive experience in drug development, production, and commercialization. |
| Deloitte Financial Advisory | Financial Advisor to Polifarma | Company | Provided financial advisory services, including M&A and debt advisory, for Polifarma's acquisition of Hennig. |
| EY Legal Transaction | Legal Advisor to Polifarma | Company | Offered legal advisory services, particularly in contract negotiations and financing for Polifarma. |
| RSM Ebner Stolz | Financial and Legal Advisor to Hennig | Company | Advised Hennig on financial and legal aspects of the acquisition by Polifarma. |